MSD launches Januvia 25mg, completing portfolio for nephropathy patients

Published: 2017-03-31 13:55:06

Updated: 2017-03-31 13:55:06

Because launching Januvia 25mg, MSD has become available to make prescriptions for nephropathy patients on every stage.

At the press conference on the 29^th, MSD Korea announced the launch of the diabetes type 2 treatment ‘Januvia(generic name: sitagliptin) 25mg’ on April.

Although Januvia 100mg and 50mg have already been commercialized in Korea, since it is necessary for nephropathy patients ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.